Abstract
Epidermal growth factor receptor (EGFR)-mutant lung adenocarcinoma (LUAD) patients often respond to EGFR tyrosine kinase inhibitors (TKIs) initially b......
小提示:本篇文献需要登录阅读全文,点击跳转登录